The content of the heart failure multidisciplinary care pathway and this website were independently drafted and shaped by the Belgian Working Group of Heart Failure (BWGHF)

We thank our industry partners for helping to support this project.

In 2024, we launched the care pathway with the help of Alnylam Pharmaceuticals, Novartis, Pfizer, Bayer, Medtronic, Abbott, Servier, Daiichi-Sankyo, Roche, Vifor Pharma, AstraZeneca, Boehringer Ingelheim and Biotronik. Thanks to further annual support from Novartis, Abbott, Alnylam Pharmaceuticals, Pfizer, Bayer, Boehringer Ingelheim, Novo Nordisk, Boston Scientific, Bristol Myers Squibb, AstraZeneca and Biotronik, we can keep the website up to date this year as well.